Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Depreciation & Amortization - Total (2020 - 2021)

Immunocore Holdings' Depreciation & Amortization - Total history spans 2 years, with the latest figure at $519725.9 for Q3 2021.

  • On a quarterly basis, Depreciation & Amortization - Total fell 41.12% to $519725.9 in Q3 2021 year-over-year; TTM through Jun 2022 was $519725.9, a 81.06% decrease, with the full-year FY2020 number at $856972.7, changed N/A from a year prior.
  • Depreciation & Amortization - Total hit $519725.9 in Q3 2021 for Immunocore Holdings, down from $525545.8 in the prior quarter.
  • Over the last five years, Depreciation & Amortization - Total for IMCR hit a ceiling of $882703.9 in Q3 2020 and a floor of $478485.5 in Q1 2021.